[Bone and metabolism]

Ann Endocrinol (Paris). 2018 Sep:79 Suppl 1:S40-S47. doi: 10.1016/S0003-4266(18)31236-8.
[Article in French]

Abstract

Bone is now considered as a particular endocrine organ. Its endocrine function is not yet fully understood and has been the subject of several conferences at the European Society of Endocrinology Congress 2018. Bone regulates phosphate metabolism by secreting fibroblast growth factor 23; it also regulates glucose metabolism via osteocalcin and energy metabolism, thanks to lipocalin 2, a new hormone acting on the brain. In addition, the incidence of diabetes continues to grow, and its impact on bone has been demonstrated, with an increased risk of fractures regardless the type of diabetes. The mechanism of bone fragility in this disease is not fully known but it involves a decrease in bone turnover and bone demineralization. Recent findings on the role of bone on glucose and mineral metabolism could open therapeutic perspectives, especially for the treatment of diabetes or obesity.

Keywords: Bone; Diabetes; Diabète; Energy metabolism; Métabolisme énergétique; Os.

MeSH terms

  • Bone Demineralization, Pathologic / etiology
  • Bone Remodeling
  • Bone and Bones / physiology*
  • Diabetes Complications
  • Diabetes Mellitus / epidemiology
  • Endocrine Glands / physiology
  • Energy Metabolism
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors / physiology
  • Fractures, Bone / etiology
  • Glucose / metabolism
  • Humans
  • Lipocalin-2 / physiology
  • Metabolism / physiology*
  • Minerals / metabolism
  • Osteocalcin / physiology
  • Phosphates / metabolism
  • Risk Factors

Substances

  • Lipocalin-2
  • Minerals
  • Phosphates
  • Osteocalcin
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Glucose